MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Submandibular gland is a suitable tissue for alpha synuclein pathology in Parkinson’s disease

    JH. Shin, SH. Park, CW. Shin, JH. Kim, TJ. Yun, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To validate the role of α-synuclein (AS) pathology in submandibular gland (SMG) as a biomarker for Parkinson disease (PD). Background: The pathologic hallmark of…
  • 2018 International Congress

    STN-DBS responsive motor complication and pathological gambling in type IV SCA3

    M. Kuo, C. Tai, R. Wu (New Taipei, Taiwan)

    Objective: Background: Type IV spinocerebellar ataxia type 3 (SCA3) could present as pure parkinsonism. A bilateral subthalamic nucleus deep brain stimulation (STN-DBS) has been reported…
  • 2018 International Congress

    CRISPR/Cas9-based fluorescent tyrosine hydroxylase-reporter lines

    A. Rakovic, F. Vulinovic, C. Klein (Lübeck, Germany)

    Objective: To generate and characterize TH-GFP and -mCherry reporter iPSC lines. Background: Human induced pluripotent stem cells (iPSCs)-based dopaminergic neuronal (iDA) cultures emerged as a…
  • 2018 International Congress

    Improving compliance to Parkinsonism’s pharmacotherapy amongst patients attending a Movement Disorders Clinic (MDC)

    M. Alsahab, S. Pradhan, A. Chatterjee (Reading, United Kingdom)

    Objective: To improve patients’ compliance with Parkinsonism's pharmacotherapy to achieve more accurate clinical assessment in an outpatient setting. Background: Patients with Parkinsonism are encouraged to…
  • 2018 International Congress

    What increases the risk of malnutrition in geriatric Parkinson’s disease population?

    M. Gultekin, F. Fırat Ozer, S. Akın, A. Ozturk (Kayseri, Turkey)

    Objective: The aim of the this study is to determine the risk of the malnutrition in geriatric Parkinson's disease population. Background: Among the patients with…
  • 2018 International Congress

    Non-motor symptoms in patients from the Catalonian Multiple System Atrophy Registry (CMSAR)

    D.M. Giraldo, A. Pérez Soriano, J. Rios Guillermo, E. Muñoz, Y. Compta, J. Pagonabarraga, F. Valldeoriola, J. Hernández-Vara, S. Jauma Classen, V. Puente, C. Pont, N. Caballol, E. Tolosa, A. Bayes, J. Campdelacreu, O. Fabregues, A. Avila, M. Calopa, C. Gaig, N. Fabregat, P. Pastor, M. Aguilar, M. Pujol, L. Planellas, A. Camara, M.J. Marti (Barcelona, Spain)

    Objective: To assess non-motor symptoms (NMS) and their demographic and clinical correlates in MSA patients included in the CMSAR. Background: NMS are an important and…
  • 2018 International Congress

    ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy

    N. Mendonca, R. Bateman, A. Boxer, J. Braunstein, D. Claassen, D. Holtzman, D. Kerwin, B. Rendenbach-Mueller, H. Soares, D. Wang, G. Höglinger (Ludwigshafen, , Germany)

    Objective: This double-blind, placebo-controlled phase 2 study (M15-562 ARISE study, NCT02985879) assesses the safety and efficacy of ABBV-8E12 treatment in patients with progressive supranuclear palsy…
  • 2018 International Congress

    Motor and cognitive deficits in a mouse model of tauopathy with tau isoforms imbalance: Potential therapeutic strategies

    ME. Avale, SL. Espindola, A. Damianich, M. Sartor, J. Ferrario (Buenos Aires, Argentina)

    Objective: This work investigates motor phenotypes and neurochemical changes in a mouse model of tauopathy linked to tau mis-splicing. We sought to validate a potential…
  • 2018 International Congress

    Midbrain/pons area ratio and clinical features predict the prognosis of PSP

    S. Cui, S. Chen (Shanghai, People’s Republic of China)

    Objective: This study aims to characterize the natural history of PSP and to find predictors of shorter survival and early institutionalization including neuroimaging biomarkers. Background:…
  • 2018 International Congress

    Affective impairment and emotional tone of early Richardson’s syndrome and Progressive Supranuclear Palsy with predominant parkinsonism: The role of Alexithymia and Anhedonia

    C. Pellicano, F. Assogna, L. Cravello, C. Savini, M. Pierantozzi, A. Stefani, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)

    Objective: To define qualitative and quantitative differences of alexithymia and anhedonia among Progressive Supranuclear Palsy (PSP) with predominant parkinsonism (PSP-P), Richardson’s syndrome (PSP-RS) and Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley